Effect of calcitonin gene related peptide vs sodium nitroprusside to increase temperature in spontaneous canine tumours during local hyperthermia

References

• Dewhirst M, Jones E, Samulski T, Vujaskovic Z, Li CY, Prosnitz LR. Hyperthermia. In: Kufe D, Pollock R, Weichselbaum R, Bast R, Gansler T, Holland J, Frei E, eds, Cancer Medicine, 6th edn. Hamilton: BC Decker, Inc, 2003; 623–36.
   Google Scholar
• Voorhees WD 3rd, Babbs CF. Hydralazine-enhanced selective heating of transmissible venereal tumor implants in dogs. Eur J Cancer Clin Oncol 1982; 18: 1027–33.
   Google Scholar
• Horsman MR, Christensen KL, Overgaard J. Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo. Int J Hypertherrnia 1989; 5: 123–36.
   Google Scholar
• Kalmus J, Okunieff P, Vaupel P. Dose-dependent effects of hydralazine on microcir-culatory function and hyperthermic response of murine FSall tumors. Cancer Res 1990; 50: 15–9.
   Google Scholar
• Dewhirst MW, Prescott DM, Clegg S, Samulski TV, Page RL, Thrall DE, Leopold K, Rosner G, Acker JC, Oleson JR. The use of hydralazine to manipulate tumour tempera-tures during hyperthermia. Int J Hypertherrnia 1990; 6: 971–83.
   PubMed Web of Science ®Google Scholar
• Hasegawa T, Song CW. Effect of hydralazine on the blood flow in tumors and normal tissues in rats. Int J Radiat Oncol Biol Phys 1991; 20: 1001–7.
   PubMed Web of Science ®Google Scholar
• Honess DJ, Hu DE, Bleehen NM. A study of the mechanism of hydralazine enhancement of thermal damage in the KHT tumour. Int J Hypertherrnia 1991; 7: 667–79.
   Google Scholar
• Krossnes BK, Mella O, Dahl O. Use of the vasodilator sodium nitroprusside during local hyperthermia: effects on tumor temperature and tumor response in a rat tumor model. Int J Radiat Oncol Biol Phys 1996; 36: 403–15.
   Google Scholar
• Krossnes BK, Mella O, Tyssebotn I. Effect of sodium nitroprusside-induced hypotension on the blood flow in subcutaneous and intramuscular BT4AN tumors and normal tissues in rats. Int J Radiat Oncol Biol Phys 1996; 36: 393–401.
   Google Scholar
• Oates JA, Brown NJ. Antihypertensive agents and the drug therapy of hypertension. In: Hardman JG, Limbird LE, eds, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th edn. New York: McGraw-Hill, 2001; pp. 871–900.
   Google Scholar
• von Ardenne M, Reitnauer PG. Selective occlusion of cancer tissue capillaries as the central mechanism of the cancer multistep therapy. Jpn J Clin Oncol 1980; 10: 48.
   Google Scholar
• von Ardenne M, Kruger W. The use of hyperthermia within the frame of cancer multistep therapy. Ann NY Acad Sci 1980; 335: 356–61.
   PubMedGoogle Scholar
• Krossnes BK, Geisler S, Mella O. Intravenous infusion of glucose and the vasodilator sodium nitroprusside in combination with local hyperthermia: effects on tumour pH and tumour response in the BT4An rat tumour model. Int J Hypertherrnia 1998; 14: 403–16.
   Google Scholar
• Krossnes BK, Hornsleth SN. Use of the vasodilator sodium nitroprusside to increase tumour temperature during loco-regional hyperthermia with a capacitive ring applicator in a rat tumour model. Int J Hypertherrnia 2002; 18: 292–306.
   PubMed Web of Science ®Google Scholar
• Prescott DM, Samulski TV, Dewhirst MW, Page RL, Thrall DE, Dodge RK, Oleson JR. Use of nitroprusside to increase tissue temperature during local hyperthermia in normal and tumor-bearing dogs. Int J Radiat Oncol Biol Phys 1992; 23: 377–85.
   Google Scholar
• Struthers AD, Brown MJ, Macdonald DW, Beacham JL, Stevenson JC, Morris HR, MacIntyre I. Human calcitonin gene related peptide: a potent endogenous vasodilator in man. Clin Sci (Colch) 1986; 70: 389–93.
   Google Scholar
• Burney IA, Maxwell RJ, Griffiths JR, Field SB. The potential for prazosin and calcitonin gene-related peptide (CGRP) in causing hypoxia in tumours. Br J Cancer 1991; 64: 683–8.
   PubMedGoogle Scholar
• Crezee J, Lagendijk M. Experimental verification of bioheat transfer theories: measure-ment of temperature profiles around large artificial vessels in perfused tissue. Phys Med Biol 1990; 35: 905–23.
   PubMed Web of Science ®Google Scholar
• Craciunescu OI, Raaymakers BW, Kotte AN, Das SK, Samulski TV, Lagendijk M. Discretizing large traceable vessels and using DE-MRI perfusion maps yields numerical temperature contours that match the MR noninvasive measurements. Med Phys 2001; 28: 2289–96.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Tso CY, Oliver R, Gustafson CS, Secomb TW, Gross JF. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. Int J Radiat Oncol Biol Phys 1989; 17: 91–9.
   PubMed Web of Science ®Google Scholar
• Dewhirst M. Angiogenesis and blood flow in solid tumors. In: Teicher B, ed, Drug Resistance in Oncology. New York: Marcel Dekker, Inc., 1993; pp. 3–24.
   Google Scholar
• Samulski TV, Fessenden P, Lee ER, Kapp DS, Tanabe E, McEuen A. Spiral microstrip hyperthermia applicators: technical design and clinical performance. Int J Radiat Oncol Biol Phys 1990; 18: 233–42.
   PubMed Web of Science ®Google Scholar
• Thrall DE, Rosner GL, Azuma C, Larue SM, Case BC, Samulski T, Dewhirst MW. Using units of CEM 43 degrees C T90, local hyperthermia thermal dose can be delivered as prescribed. Int J Hypertherrnia 2000; 16: 415–28.
   Google Scholar
• Dewhirst MW, Phillips TL, Samulski TV, Stauffer P, Shrivastava P, Paliwal B, Pajak T, Gillim M, Sapozink M, Myerson R, Waterman FM, Sapareto SA, Corry P, Cetas TC, Leeper DB, Fessenden P, Kapp D, Oleson JR, Emami B. RTOG quality assurance guide-lines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 1990; 18: 1249–59.
   PubMed Web of Science ®Google Scholar
• Leopold KA, Dewhirst M, Samulski T, Harrelson J, Tucker JA, George SL, Dodge RK, Grant W, Clegg S, Prosnitz LR, Oleson JR. Relationships among tumor temperature, treatment time, and histopathological outcome using preoperative hyperthermia with radiation in soft tissue sarcomas. Int J Radiat Oncol Biol Phys 1992; 22: 989–98.
   Google Scholar
• Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys 1984; 10: 787–800.
   PubMed Web of Science ®Google Scholar
• Oleson JR, Samulski TV, Leopold KA, Clegg ST, Dewhirst MW, Dodge RK, George SL. Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment. Int J Radiat Oncol Biol Phys 1993; 25: 289–97.
   Google Scholar
• Seegenschmiedt MH, Martus P, Fietkau R, Iro H, Brady LW, Sauer R. Multivariate analysis of prognostic parameters using interstitial thermoradiotherapy (IHT-IRT): tumor and treatment variables predict outcome. Int J Radiat Oncol Biol Phys 1994; 29: 1049–63.
   PubMed Web of Science ®Google Scholar
• Kapp DS, Cox RS. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast [see comments]. Int J Radiat Oncol Biol Phys 1995; 33: 887–99.
   PubMed Web of Science ®Google Scholar
• Hand JW, Machin D, Vernon CC, Whaley JB. Analysis of thermal parameters obtained during phase III trials of hyperthermia as an adjunct to radiotherapy in the treatment of breast carcinoma. Int J Hypertherrnia 1997; 13: 343–64.
   PubMed Web of Science ®Google Scholar
• Sherar M, Liu FF, Pintilie M, Levin W, Hunt J, Hill R, Hand J, Vernon C, van Rhoon G, van der Zee J, Gonzalez DG, van Dijk J, Whaley J, Machin D. Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys 1997; 39: 371–80.
   Google Scholar
• Dewhirst MW, Viglianti BL, Lora-Michiels M, Hanson M, Hoopes PJ. Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia. Int J Hypertherrnia 2003; 19: 267–94.
   Google Scholar
• D'Ippolito G, Goldberg SN. Radiofrequency ablation of hepatic tumors. Tech Vase Interv Radiol 2002; 5: 141–55.
   PubMedGoogle Scholar